Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 ,inter alia, to consider and approve 1. To consider and evaluate ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Ltd has informed BSE that its Board of Directors will meet on January 15, 2026, to consider and evaluate a proposal for raising funds. The company is exploring issuance of equity shares, warrants convertible into equity shares, or other securities through preferential issue, private placement, or any other permitted mode under SEBI rules. The Board will also consider calling a general meeting of shareholders to seek their approval for the fund-raising plan. The trading window for insiders is already closed from January 1, 2026, and will remain shut until 48 hours after the declaration of Q3 FY26 unaudited financial results. No specific amount, pricing, or investor details have been disclosed yet — everything is at the consideration stage.
This is only a preliminary intimation, so the stock may see some speculative interest ahead of the board meeting. If the fund-raising plan materialises, existing shareholders could face equity dilution depending on the instrument and size finally approved. Investors should wait for the January 15 outcome for clarity on quantum, pricing, and use of proceeds.